Trevino Jessica M, Christein John D, Varadarajulu Shyam
Division of Gastroenterology-Hepatology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
Gastrointest Endosc. 2009 Oct;70(4):793-7. doi: 10.1016/j.gie.2009.05.023. Epub 2009 Jul 31.
Although several large series have reported on EUS-guided transgastric and transduodenal drainage of peripancreatic fluid collections (PFCs), only commentary on individual cases has been presented on EUS-guided transesophageal drainage of PFCs.
To evaluate the technical success and safety of EUS-guided transesophageal drainage of PFCs.
Observational study.
Tertiary academic referral center.
This study involved 3 consecutive patients referred for EUS-guided transesophageal drainage of PFCs over a 3-year period.
The PFCs were accessed via the transesophageal route under EUS-guidance by using a 19-gauge needle. After a 0.035-inch guidewire was passed into the PFC, and the transmural tract was dilated to 6 mm, a transmural stent and/or drainage catheter was deployed.
Evaluation of the technical and treatment success and safety profile of EUS-guided transesophageal drainage of PFCs.
Three male patients (mean age 57.8 years [range 49-75 years]) underwent EUS-guided transesophageal drainage of PFCs (2 pseudocyst, 1 abscess) over a 3-year period. The etiology of the PFC was alcohol abuse in 2 patients and postsurgical in 1. The mean size of the PFCs was 7 cm (range 6-8 cm) in its largest dimension. The procedures were technically successful in all 3 patients, and no complications were encountered. All 3 patients had a successful treatment outcome. At a mean follow-up period of 24 months (range 12-36 months), all patients were doing well, without any evidence of PFC recurrence.
Small number of patients.
In experienced hands, EUS-guided transesophageal drainage of PFCs is technically feasible and safe and is associated with favorable clinical outcomes. A long-term follow-up with larger numbers of patients is required to determine whether the procedure could be an effective alternative to surgical cyst-enterostomy or percutaneous drainage techniques.
尽管已有多个大型系列报道了超声内镜引导下经胃和经十二指肠引流胰周液体积聚（PFC），但关于超声内镜引导下经食管引流PFC的报道仅为个别病例的评论。
评估超声内镜引导下经食管引流PFC的技术成功率和安全性。
观察性研究。
三级学术转诊中心。
本研究纳入了3年内连续3例因超声内镜引导下经食管引流PFC而转诊的患者。
在超声内镜引导下，经食管途径使用19G穿刺针进入PFC。在将一根0.035英寸的导丝送入PFC后，将经壁通道扩张至6mm，然后置入经壁支架和/或引流导管。
评估超声内镜引导下经食管引流PFC的技术成功率、治疗成功率及安全性。
3例男性患者（平均年龄57.8岁[范围49 - 75岁]）在3年内接受了超声内镜引导下经食管引流PFC（2例为假性囊肿，1例为脓肿）。2例PFC的病因是酒精滥用，1例是术后所致。PFC的最大直径平均为7cm（范围6 - 8cm）。所有3例患者手术技术均成功，未发生并发症。所有3例患者治疗均成功。平均随访24个月（范围12 - 36个月）时，所有患者情况良好，无PFC复发迹象。
患者数量少。
在经验丰富的医生操作下，超声内镜引导下经食管引流PFC在技术上是可行且安全的，并且临床效果良好。需要对更多患者进行长期随访，以确定该操作是否可成为外科囊肿肠吻合术或经皮引流技术的有效替代方法。
Zotero 插件